FDA Approves First Oral Cholesterol Pill to Match Injectable Potency
The US Food and Drug Administration has approved Lipfendra, the first pill that works by the same mechanism as the most powerful injectable cholesterol drugs on the market. Made by Merck, the once-daily tablet cuts LDL cholesterol by up to 59 percent in clinical trials..
